Skip to content
Trial Eligibility
Menu

PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing

NCT02282969

This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Objectives: This protocol addresses the first phase of a larger project funded by the Patient-Centered Outcomes Research Institute to help heavy smokers make informed decisions about lung cancer screening with low-dose computed tomography (CT). A separate IRB protocol will be submitted for the larger, comparative study. In this initial development phase, our prototype patient decision aid will be updated to reflect current guidelines about lung cancer screening. The updated aid will then be pilot-tested in a new sample of patients.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Health Knowledge, Attitudes, Practice

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
55 to 80 years
Sex
All
Healthy volunteers
Accepted
Sponsor
M.D. Anderson Cancer Center
Last updated on ClinicalTrials.gov
July 16, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 2

  • The University of Texas Medical Branch at Galveston · Galveston, TX
  • University of Texas MD Anderson Cancer Center · Houston, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.